➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
McKesson
Dow
Express Scripts

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Haloperidol - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for haloperidol and what is the scope of freedom to operate?

Haloperidol is the generic ingredient in six branded drugs marketed by Ortho Mcneil, Ortho Mcneil Pharm, Appco, Cycle Pharms Ltd, Duramed Pharms Barr, Innogenix, Lederle, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sandoz, SCS, Vintage, Watson Labs, Zydus Pharms Usa, Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Somerset Theraps Llc, Teva Pharms Usa, West-ward Pharms Int, Zydus Pharms, Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Teva, Teva Pharms, Hikma, Abraxis Pharm, Akorn, Baxter Hlthcare Corp, Fosun Pharma, Marsam Pharms Llc, Sagent Pharms, Smith And Nephew, Solopak, and Actavis Mid Atlantic, and is included in one hundred and ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol. Eighteen suppliers are listed for this compound.

Drug Prices for haloperidol

See drug prices for haloperidol

Drug Sales Revenue Trends for haloperidol

See drug sales revenues for haloperidol

Recent Clinical Trials for haloperidol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of CalgaryPhase 4
Services Institute of Medical Sciences, PakistanPhase 1
Canadian Institutes of Health Research (CIHR)Phase 4

See all haloperidol clinical trials

Pharmacology for haloperidol
Medical Subject Heading (MeSH) Categories for haloperidol

US Patents and Regulatory Information for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage HALOPERIDOL haloperidol TABLET;ORAL 071235-001 Nov 3, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm HALOPERIDOL haloperidol TABLET;ORAL 071328-001 Jul 20, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Cycle Pharms Ltd HALOPERIDOL haloperidol TABLET;ORAL 071128-001 Feb 17, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Cycle Pharms Ltd HALOPERIDOL haloperidol TABLET;ORAL 071132-001 May 12, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HALOPERIDOL haloperidol TABLET;ORAL 071374-001 Jun 3, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Duramed Pharms Barr HALOPERIDOL haloperidol TABLET;ORAL 071218-001 Dec 4, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-006 Feb 2, 1982   Start Trial   Start Trial
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-004 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-003 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-005 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.